Clinical trial

A Pilot Clinical Trial With the Iron Chelator Deferiprone in Parkinson's Disease

NCT01539837

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Deferiprone 20mg Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Deferiprone 30mg Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Pilot Clinical Trial With the Iron Chelator Deferiprone in Parkinson's Disease

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-02-01

PhasePHASE2

Conditions

Parkinson's Diseaseverified · MONDO: Parkinson disease

Interventions

Deferiprone 20mgDRUG

PlaceboDRUG

Deferiprone 30mgDRUG

Sponsors & collaborators

Imperial College Londonlead sponsor

Mapped research locations

LondonUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01539837 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.